TCT Round-Up: The Next Generation Of Drug-Eluting Stents, Drug-Coated Balloon Featured At Washington Conference
One of the world’s largest showcases for new interventional cardiology technology, the 2016 Transcatheter Cardiovascular Therapeutics (TCT) 2016 scientific sessions, were held Oct. 29-Nov. 2 in Washington, DC. This year’s edition of TCT featured many presentations on new drug-eluting coronary stent technologies, as well as drug-coated balloons for peripheral interventions.
You may also be interested in...
US Approvals Analysis: Drug-Coated Balloon, Valve Tech Are July Highlights
July was a relatively light month for novel-device approvals by US FDA, but year-to-date volumes remain strong. Spotlighted devices include approval of a new drug-coated balloon and heart valve devices. Here's a roundup from Medtech Insight's Approval Tracker.
Philips Grows Image-Guided Intervention Focus With Spectranetics Buy
In its second acquisition this month and fourth this year, Philips is buying US device maker Spectranetics Corp. for about $2bn to add laser atherectomy catheters to its vascular imaging line-up.
EuroPCR 2017: TAVR Continues To Beat Surgery; Bioabsorbable Stents Not Going Away
The EuroPCR conference in Paris is the most important annual interventional cardiology conference in Europe and this year's edition brought more data from clinical trials of both established catheter-based technologies and innovative new devices.